SCHEMBL901366

SCHEMBL901366

O=S(=O)(Nc1ccc(F)c(F)c1Nc1ccc(I)cc1F)c1cc(Cl)c(Cl)s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP2K1 Q02750 15/20 0.47
MAP2K2 P36507 10/20 0.47
PTGES2 Q9H7Z7 1/20 0.44
ACLY P53396 1/20 0.40
CA2 P00918 1/20 0.39
HDAC3 O15379 2/20 0.39
HDAC4 P56524 2/20 0.39
HDAC1 Q13547 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC10 Q969S8 2/20 0.39
HDAC11 Q96DB2 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC9 Q9UKV0 2/20 0.39
HDAC5 Q9UQL6 2/20 0.39
PIM1 P11309 1/20 0.38
CAMK2B Q13554 1/20 0.38
CCR1 P32246 1/20 0.38
CCR2 P41597 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL388128 0.89 MAP2K1 (0.46) MAP2K1MAP2K2CA2HDAC3HDAC4
SCHEMBL391758 0.86 MAP2K1 (0.48) MAP2K1MAP2K2PTGES2CA2
SCHEMBL388160 0.83 MAP2K1 (0.47) MAP2K1MAP2K2ACLYCA2PIM1
SCHEMBL393218 0.82 THRB (0.59) MAP2K1MAP2K2CA2HDAC3HDAC4
SCHEMBL393069 0.81 MAP2K1 (0.48) MAP2K1MAP2K2CA2PIM1CAMK2B
SCHEMBL9994842 0.80 MAP2K1 (0.47) MAP2K1MAP2K2CA2PIM1CAMK2B
SCHEMBL685700 0.80 MAP2K1 (0.49) MAP2K1MAP2K2CA2CCR2
SCHEMBL392182 0.80 MAP2K1 (0.49) MAP2K1MAP2K2ACLYCA2CCR2
SCHEMBL391250 0.79 MAP2K1 (0.48) MAP2K1MAP2K2CA2HDAC3HDAC4
SCHEMBL5090048 0.78 PTGES2 (0.51) MAP2K1MAP2K2PTGES2ACLYCCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2621486-A1 SUBSTITUTED N-(2-ARYLAMINO)ARYL SULFONAMIDE-CONTAINING COMBINATIONS Bayer Intellectual Property GmbH (DE) 2013-08-07 EP claimed
WO-2012041987-A1 SUBSTITUTED N-(2-ARYLAMINO)ARYL SULFONAMIDE-CONTAINING COMBINATIONS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-04-05 WO claimed